Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Off-season doesn't allow brain to recover from football hits, study says

  • Rapid whole-brain imaging with single cell resolution

  • Trisomy 21: How an extra little chromosome throws entire genome off balance

  • Anti-seizure drug may reduce alcohol consumption, study shows

  • The ilk of human kindness: Older women with gumption score high on compassion

  • Our relationship with God changes when faced with potential romantic rejection

  • Sporting latest tech toy can make you seem more like a leader

  • Progressive neurodegenerative disorder linked to R-loop formation

  • New pain relief targets discovered by researchers

  • Better way to deal with bad memories suggested

  •